Targeting angiogenesis for treatment of human cancer

about

Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction.Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.

P2860

Q37595420-FBAEC18A-83F9-4EB4-90A0-73F78CC45444 Q47440128-BB3115AD-D099-4C39-8046-0BB2AD65DF2B

P2860

Targeting angiogenesis for treatment of human cancer

Item

http://www.wikidata.org/entity/Q38125442

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Targeting angiogenesis for treatment of human cancer

@en

type

Item

label

Targeting angiogenesis for treatment of human cancer

@en

prefLabel

Targeting angiogenesis for treatment of human cancer

@en

P1476

Targeting angiogenesis for treatment of human cancer

@en

P2093

R R Somani

http://www.w3.org/2001/XMLSchema#string

U V Bhanushali

http://www.w3.org/2001/XMLSchema#string

P2860

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

1.8-A crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile

Cetuximab for the treatment of colorectal cancer.

Tumor angiogenesis: therapeutic implications

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors

Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials

Angiogenesis as a therapeutic target

What is the evidence that tumors are angiogenesis dependent?

New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis.

P304

3-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0250-474X.113529

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23901154

http://www.w3.org/2001/XMLSchema#string

P932

3719146

http://www.w3.org/2001/XMLSchema#string

Targeting angiogenesis for treatment of human cancer

about

P2860

P2860

Targeting angiogenesis for treatment of human cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932